Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Németország
33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Frankfurt, Frankfurt am Main, Hamburg, Landsberg Am Lech, Leipzig, Mainz, Rheine
- Életkor
- 40 év to 75 év
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - 3. fázisTaking peopleA Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- Where
- Freiburg im Breisgau
- Életkor
- 18 év to 80 év
- People
- 40 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00 - 2. fázisTaking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Ahrensburg, Bendorf, Berlin, Darmstadt, Halle, Hanover, Landsberg, Leipzig, Lübeck, Marburg, Obertshausen, Rosenheim, Schleswig, Wiesbaden, Witten
- Életkor
- 40 év and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Where
- Bamberg, Berlin, Bonn, Landsberg am Lech, Peine, Witten
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00 - 2/3. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Where
- Ahrensburg, Bendorf, Berlin, Delitzsch, Essen, Frankfurt am Main, Leipzig
- Életkor
- 35 év to 80 év
- People
- 1156 worldwide
- Run by
- Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00 - No phaseNot yet taking people in NémetországUpper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High Flow: An MRI Study
- Where
- Dortmund
- Életkor
- 18 év and over
- People
- 20
- Run by
- Klinikum Dortmund Wirbelsäulenchirurgie
See details and how to joinNCT07886502 - 4. fázisTaking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- Berlin, Mainz
- Életkor
- 40 év to 85 év
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - No phaseTaking peopleBronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Where
- Heidelberg
- Életkor
- 40 év to 84 év
- People
- 250 worldwide
- Run by
- Apreo Health, Inc.
See details and how to joinNCT06891755 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Ahrensburg, Augsburg, Bendorf, Berlin, Darmstadt, Frankfurt, Frankfurt am Main, Hamburg, Leipzig, Lübeck, Mainz, Munich
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - No phaseTaking peopleInduced Sputum Collection in COPD Patients With and Without a Vibroacoustic Device
- Where
- Hanover
- Életkor
- 40 év and over
- People
- 20
- Run by
- Fraunhofer-Institute of Toxicology and Experimental Medicine
See details and how to joinNCT07751705 - 2. fázisNot yet taking people in NémetországA Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
- Where
- Berlin, Cologne, Essen, Frankfurt Am Main, Hamburg
- Életkor
- 18 év and over
- People
- 183 worldwide
- Run by
- Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 · EU 2026-525216-34-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- Where
- Ahrensburg, Bad Berka, Berlin, Bonn, Cologne, Donaustauf, Essen, Frankfurt, Frankfurt am Main, Giessen, Kiel, Loewenstein, Mainz, München, Peine, Wiesbaden, Wuerzburg, Wuppertal
- Életkor
- 40 év to 80 év
- People
- 981 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- Where
- Bendorf, Berlin, Darmstadt, Essen, Fürstenwalde, Geesthacht, Giessen, Halle, Homburg, Immenhausen, Leipzig, Luebeck, München, Offenbach Am Main, Rheine, Schleswig
- Életkor
- 40 év to 80 év
- People
- 961 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00 - 3. fázisTaking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Ahrensburg, Augsburg, Bamberg, Berlin, Cottbus, Darmstadt, Essen, Frankfurt am Main, Hamburg, Hannover, Hanover, Ibbenbüren, Landsberg Am Lech, Leipzig, Luebeck, Mainz, Marburg, Moers, Munich, Offenbach Am Main, Peine, Rheine, Riesa, Rosenheim, Solingen, Wallerfing, Wermsdorf, Wiesbaden, Witten
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - 4. fázisTaking peopleA Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
- Where
- Ahrensburg, Berlin, Frankfurt am Main, Hanover
- Életkor
- 40 év to 80 év
- People
- 56 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07073950 · EU 2025-521987-37-00 - No phaseTaking peopleAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Where
- Essen, Halle, Hamburg, Heidelberg, Hemer
- Életkor
- 40 év to 80 év
- People
- 200 worldwide
- Run by
- Pulmonx Corporation
See details and how to joinNCT06035120 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Where
- Bendorf, Berlin, Hanover, Immenhausen, Marburg, Rosenheim, Wiesbaden
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00 - 1. fázisTaking peopleA Study to Evaluate the Safety and Activity of an Inhaled Investigational Drug (RO7616605) in Healthy Volunteers and Participants With COPD
- Where
- Berlin, Hanover
- Életkor
- 18 év and over
- People
- 104
- Run by
- Genentech Inc.
See details and how to join2025-525042-22-00 · EU 2025-525042-22-00 - 2. fázisTaking peopleA study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
- Where
- Bendorf, Berlin, Darmstadt, Halle, Hanover, Landsberg Am Lech, Leipzig, Luebeck, Marburg, Obertshausen, Rosenheim, Schleswig, Wiesbaden, Witten
- Életkor
- 18 év and over
- People
- 307 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-520473-40-00 · EU 2025-520473-40-00 - 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Ahrensburg, Bendorf, Berlin, Bonn, Essen, Frankfurt, Frankfurt am Main, Hamburg, Heidelberg, Leipzig, Loewenstein, Mainz, Marburg, München, Wuppertal
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - 4. fázisTaking peopleMolecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
- Where
- Marburg
- Életkor
- 40 év and over
- People
- 135 worldwide
- Run by
- Maria Joyera Rodríguez
See details and how to joinNCT06334575 - No phaseTaking peopleThe CATALINA Study
- Where
- Großhansdorf, Itzehoe, Kiel, Marburg
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Wim Janssens
See details and how to joinNCT05008081 - No phaseNot yet taking people in NémetországInvestigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -
- Where
- Borstel, Kiel
- Életkor
- 18 év and over
- People
- 100
- Run by
- Research Center Borstel
See details and how to joinNCT07386912 - No phaseTaking peopleSympathetic Nerve Activity Predictors in Patients With Chronic Obstructive Pulmonary Disease
- Where
- Aachen
- Életkor
- 18 év and over
- People
- 135
- Run by
- RWTH Aachen University
See details and how to joinNCT04849806 - No phaseTaking peopleDiaphragmatic Function as a Biomarker
- Where
- Aachen
- Életkor
- 18 év and over
- People
- 800
- Run by
- RWTH Aachen University
See details and how to joinNCT05903001